Assessment of Salbutamol Effect on Arterial Oxygenation in COPD Patients During One-lung Ventilation

NCT05914285 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

One-lung Ventilation
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: 5ml of inhaled normal saline
DRUG: 2.5mg (2.5ml) of inhaled salbutamol and 2.5ml of inhaled normal saline

Sponsor

Yonsei University